TW201100090A - C6orf167 peptides and vaccines containing the same - Google Patents

C6orf167 peptides and vaccines containing the same Download PDF

Info

Publication number
TW201100090A
TW201100090A TW099109539A TW99109539A TW201100090A TW 201100090 A TW201100090 A TW 201100090A TW 099109539 A TW099109539 A TW 099109539A TW 99109539 A TW99109539 A TW 99109539A TW 201100090 A TW201100090 A TW 201100090A
Authority
TW
Taiwan
Prior art keywords
peptide
cancer
identification number
sequence
c6orfl67
Prior art date
Application number
TW099109539A
Other languages
English (en)
Chinese (zh)
Inventor
Yusuke Nakamura
Yataro Daigo
Takuya Tsunoda
Ryuji Ohsawa
Sachiko Yoshimura
Tomohisa Watanabe
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of TW201100090A publication Critical patent/TW201100090A/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
TW099109539A 2009-04-01 2010-03-30 C6orf167 peptides and vaccines containing the same TW201100090A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21170009P 2009-04-01 2009-04-01

Publications (1)

Publication Number Publication Date
TW201100090A true TW201100090A (en) 2011-01-01

Family

ID=42827803

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099109539A TW201100090A (en) 2009-04-01 2010-03-30 C6orf167 peptides and vaccines containing the same

Country Status (14)

Country Link
US (1) US20120128705A1 (enExample)
EP (1) EP2414383A4 (enExample)
JP (1) JP5728759B2 (enExample)
KR (1) KR20120034605A (enExample)
CN (2) CN102448980B (enExample)
AU (1) AU2010231381A1 (enExample)
BR (1) BRPI1013384A2 (enExample)
CA (1) CA2757210A1 (enExample)
IL (1) IL215268A0 (enExample)
MX (1) MX2011010191A (enExample)
RU (1) RU2011144088A (enExample)
SG (2) SG2014011423A (enExample)
TW (1) TW201100090A (enExample)
WO (1) WO2010113495A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007013671A2 (en) 2005-07-27 2007-02-01 Oncotherapy Science, Inc. Method of diagnosing esophageal cancer
CN102884190B (zh) 2010-03-11 2016-03-23 肿瘤疗法科学股份有限公司 Hjurp肽及包含它们的疫苗
JP2013542711A (ja) * 2010-08-19 2013-11-28 オンコセラピー・サイエンス株式会社 がんの治療および診断の標的遺伝子としてのＣ６ｏｒｆ１６７

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1273499A (en) * 1997-10-24 1999-05-17 Human Genome Sciences, Inc. 148 human secreted proteins
CN1351069A (zh) * 2000-10-26 2002-05-29 上海博德基因开发有限公司 一种新的多肽——鼠的同ampa受体相互作用的蛋白grip12.54和编码这种多肽的多核苷酸
US7919467B2 (en) * 2000-12-04 2011-04-05 Immunotope, Inc. Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
CN101139392B (zh) * 2002-09-12 2012-12-26 肿瘤疗法科学股份有限公司 Kdr肽和包括该肽的疫苗
JP4628208B2 (ja) * 2004-08-10 2011-02-09 オンコセラピー・サイエンス株式会社 Ｃｘａｄｒｌ１またはｇｃｕｄ１タンパク質を発現する胃癌または結腸直腸癌の治療のためのペプチドワクチン
DK2325306T3 (en) * 2005-02-25 2014-03-03 Oncotherapy Science Inc Peptide vaccines against lung cancers expressing TTK, URLC10 or KOC1 polypeptide
WO2007013671A2 (en) * 2005-07-27 2007-02-01 Oncotherapy Science, Inc. Method of diagnosing esophageal cancer
EP2295571A1 (en) * 2005-07-27 2011-03-16 Oncotherapy Science, Inc. Method of diagnosing small cell lung cancer
JP5409658B2 (ja) * 2008-03-13 2014-02-05 セレラ コーポレーション 静脈血栓症に関連した遺伝子多型、その検出方法および使用

Also Published As

Publication number Publication date
WO2010113495A1 (en) 2010-10-07
SG174998A1 (en) 2011-11-28
EP2414383A4 (en) 2013-07-31
EP2414383A1 (en) 2012-02-08
CN104774260A (zh) 2015-07-15
BRPI1013384A2 (pt) 2016-03-29
CA2757210A1 (en) 2010-10-07
US20120128705A1 (en) 2012-05-24
CN102448980A (zh) 2012-05-09
MX2011010191A (es) 2011-11-29
RU2011144088A (ru) 2013-05-10
JP5728759B2 (ja) 2015-06-03
KR20120034605A (ko) 2012-04-12
AU2010231381A1 (en) 2011-11-03
CN102448980B (zh) 2015-04-15
JP2012522488A (ja) 2012-09-27
IL215268A0 (en) 2011-11-30
SG2014011423A (en) 2014-05-29

Similar Documents

Publication Publication Date Title
JP5799394B2 (ja) Ｎｅｉｌ３ペプチドおよびそれを含むワクチン
EP2528937B1 (en) Modified melk peptides and vaccines containing the same
JP2013523084A (ja) Ｃｄｃａ５ペプチドおよびそれを含むワクチン
KR20140057325A (ko) Ｍｐｈｏｓｐｈ１ 펩티드 및 이를 포함한 백신
JP2016222676A (ja) Ｔｏｍｍ３４ペプチドおよびそれを含むワクチン
US20120107333A1 (en) Vangl1 peptides and vaccines including the same
TW201100090A (en) C6orf167 peptides and vaccines containing the same
JP5838482B2 (ja) Ｈｊｕｒｐペプチドおよびそれを含むワクチン
JP5816965B2 (ja) Ｅｃｔ２ペプチドおよびそれを含むワクチン
TW201030018A (en) C1orf59 peptides and vaccines including the same
JP2013512659A (ja) Ｍｙｂｌ２ペプチドおよびそれを含むワクチン
TW201136604A (en) TMEM22 peptides and vaccines including the same
TW201216982A (en) WDHD1 peptides and vaccines including the same
JP2014500001A (ja) Ｃ１８ｏｒｆ５４ペプチドおよびそれを含むワクチン
TW201134480A (en) CLUAP1 peptides and vaccines including the same
TW201211250A (en) VANGL1 peptides and vaccines including the same
HK1176365B (en) Modified melk peptides and vaccines containing the same